| Recruiting | Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma Relapsed/Refractory B-cell Lymphoma | Phase 1 / Phase 2 | 2025-01-01 |
| Not Yet Recruiting | Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Pati Pancreatic Cancer | Phase 2 | 2024-02-01 |
| Recruiting | Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue) | Phase 1 / Phase 2 | 2024-01-01 |
| Recruiting | Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma Relapsed/Refractory B-cell Lymphoma | Phase 1 / Phase 2 | 2023-10-01 |
| Recruiting | BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma Multiple Myeloma in Relapse | Phase 1 / Phase 2 | 2023-07-15 |
| Recruiting | Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma Advanced Soft-tissue Sarcoma | N/A | 2022-11-11 |
| Recruiting | Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma | N/A | 2022-11-01 |
| Recruiting | CD7 CAR-T Cells in T-cell Lymphoma/Leukemia T Lymphoblastic Leukemia/Lymphoma | N/A | 2022-10-01 |
| Recruiting | Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T Advanced Pancreatic Carcinoma, Advanced Gastric Carcinoma | N/A | 2022-10-01 |
| Unknown | Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease Graft Vs Host Disease | Phase 1 / Phase 2 | 2021-08-01 |
| Unknown | CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer Advanced Pancreatic Carcinoma | Phase 1 / Phase 2 | 2021-07-01 |
| Unknown | B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple Myeloma Multiple Myeloma, Relapse Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2021-07-01 |
| Unknown | Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Relapse Leukemia, Refractory Leukemia | Phase 1 / Phase 2 | 2021-02-05 |
| Unknown | Treatment of Malignant Tumors With NK Cell Malignancy | Phase 1 / Phase 2 | 2021-02-05 |
| Unknown | Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Lymphoma Non-hodgkin Lymphoma,B Cell | Phase 1 / Phase 2 | 2021-02-05 |
| Unknown | Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine Malignant Tumor | Phase 1 / Phase 2 | 2020-10-30 |
| Unknown | Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia Dual-target CAR-T Cells, B ALL, Relapse | Phase 1 / Phase 2 | 2020-10-20 |
| Completed | The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia Acute Myeloid Leukemia (AML) | EARLY_Phase 1 | 2019-01-01 |